Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:04 PM
Ignite Modification Date:
2025-12-24 @ 10:04 PM
NCT ID:
NCT03460535
Eligibility Criteria:
Inclusion Criteria:
* patients with symptomatic monomorphic PVC with or without heart disease refractory to anti arrhythmic drugs
* patients with dilated cardiomyopathy and altered Left Ventricular Ejection Fraction (LVEF) suspected to be causes by frequent monomorphic VPC
* patients with malignant ventricular arrhythmias reproducibly induced by monomorphic PVC
Exclusion Criteria:
* patients with non-symptomatic VPC and without cardiomyopathy
* patients under 18 yo
* pregnant women
* patients with polymorphic PVC arising from clearly different areas
* patient protected by the french law: guardianship and Trusteeship
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03460535
Study Brief:
Protocol Section:
NCT03460535